SCHEMBL4150962

SCHEMBL4150962

CN(C(=O)N(COCc1ccccc1)C(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.37
FFAR4 Q5NUL3 2/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
CXCR2 P25025 1/20 0.31
KMT2A Q03164 1/20 0.31
RAB9A P51151 1/20 0.31
RORC P51449 2/20 0.31
CETP P11597 1/20 0.31
PDE2A O00408 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4163058 0.89 RORC (0.33) TDP1PPARGRORCRXFP1RORA
SCHEMBL4159030 0.88 TDP1 (0.45) TDP1MAPTLMNATSHRMAPK1
SCHEMBL4158131 0.86 RORC (0.33) TDP1MAPTLMNATSHRMAPK1
SCHEMBL5314242 0.86 TDP1 (0.36) TDP1FFAR4PPARGPPARDPPARA
SCHEMBL4145098 0.86 RORC (0.33) RORCRORARORB
SCHEMBL4149440 0.86 RORC (0.33) RORCRXFP1RORARORB
SCHEMBL4145436 0.84 TDP1 (0.36) TDP1FFAR4PPARGPPARDPPARA
SCHEMBL4157996 0.83 RORC (0.35) TDP1MAPTLMNATSHRMAPK1
SCHEMBL4142662 0.82 RORC (0.34) TDP1MAPTLMNATSHRMAPK1
SCHEMBL4141961 0.81 PPARG (0.37) TDP1PPARGPPARDPPARANR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 TDP1 1690/4885FFAR4 3283/4885PPARG 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.